Metraipolis › archive › dc_cb73e0bae440
Lysosomal vulnerability as a therapeutic target in thyroid cancer using fucoidan nanoparticles — Europe PMC PMID:42120505
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42120505
- DOI
- 10.1038/s41598-[numero omesso]-6
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T11:10:13.986Z
- SHA-256 of the archived text
f82a68926ed4b01962b5ac683b536798148e99024e99b1bf76b8a30e8bd03803- Stable URL of this page
https://metraipolis.com/documento/dc_cb73e0bae440
How to cite
Lysosomal vulnerability as a therapeutic target in thyroid cancer using fucoidan nanoparticles — Europe PMC PMID:42120505 — Europe PMC (en), https://europepmc.org/article/MED/42120505 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cb73e0bae440 (Metraipolis archive dc_cb73e0bae440, sha256 f82a68926ed4b01962b5ac683b536798148e99024e99b1bf76b8a30e8bd03803)
BibTeX
@misc{dccb73e0bae440,
title = {Lysosomal vulnerability as a therapeutic target in thyroid cancer using fucoidan nanoparticles — Europe PMC PMID:42120505},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42120505},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cb73e0bae440; sha256 f82a68926ed4b01962b5ac683b536798148e99024e99b1bf76b8a30e8bd03803},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42120505. Agents can read the archived copy with the MCP tool read_document.